Clinical TrialsSearch results
Number of results: 977
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Multicenter study for the effect preserving renal function of HMG-CoA reductase inhibitor (simvastatin) in type 2 diabetic nephropathy with hyperlipidemia (MIDN Study)
- Type 2 diabetic nephropathy with hyperlipidemia
- Japanese Society of Kidney and Lipids
- 2006-03-27
Other
- Kyushu pitavastatin and pravastatin Intervention trial on Diabetic NEphropathY
- Type 2 diabetic nephropathy with Hypercholesterolemia
- Kyushu University Graduate School of Medical Science Department of Medicine and Bioregulatory Science
- 2008-08-22
Other
- Japan Diabetes Outcome Intervention Trial 2 (J-DOIT2) The large trial to improve the medical care of the family doctors for type 2 diabetes patients and to decrease dropout rate of these patients.
- Type 2 Diabetes Mellitus
- Japan Foundation for the Promotion of International Medical Research Cooperation
- 2009-07-13
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to an Alpha-Glucosidase Inhibitor
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- Long-term effects of voglibose on diabetic complication in Japanese patients with type 2 diabetes mellitus: a double-blind, randomized, placebo-controlled clinical trial
- Type 2 diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-07
Other
- Combination of SGLT2 inhibitor and Intensive Exercise in Diabetes.
- type 2 diabetes
- Yoshihiro Ogawa
- 2019-03-15
Completed
- Investigation on Renal Protective Effect by Luseogliflozin
- type 2 diabetes
- Kitaoka Masafumi
- 2019-03-26